Renaissance Capital logo

WKME News

AI is the IPO market's next buzzword

MBLY

Major advancements in artificial intelligence (AI) have attracted billions of dollars in new investment, and the IPO market has taken notice. The percentage of US IPOs referencing AI in their prospectuses has climbed in each of the past six years, and leapt to 54% in the year-to-date period. These references range from explanations of how a company uses AI, its plans to adopt the...read more

US IPO Weekly Recap: IPO market in full swing as biotechs lead a 16 IPO week

LYEL

The IPO market was in full swing this past week as 16 IPOs and six SPACs went public. The IPO pipeline cooled down with just one IPO and nine SPACs submitting initial filings. The largest deal of the week, Lyell Immunopharma (LYEL) priced at the midpoint to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and...read more

Israeli business insight platform WalkMe prices US IPO at $31, within the range

WKME

WalkMe, an AI-powered enterprise customer engagement and business insight platform, raised $287 million by offering 9.3 million shares at $31, within the range of $29 to $32. WalkMe's no-code Digital Adoption Platform overlays any application and provides businesses with a unified view and insights across the organization's software stack to improve key business processes and drive...read more

US IPO Week Ahead: Biotechs and software lead a 15 IPO week

LYEL

Updated Monday, 6/14. 15 IPOs are currently slated to raise $2.5 billion in the week ahead, led by a preclinical biotech being valued at $4.7 billion. The largest deal of the week, Lyell Immunopharma (LYEL) plans to raise $425 million at a $4.7 billion market cap. The company is using proprietary genetic and epigenetic reprogramming to develop T...read more